The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.

Experts say sotagliflozin, known commercially as Inpefa, is the first medication of its kind ... heart attack, and stroke in patients with either heart failure or type 2 diabetes, chronic kidney ...

This is why it is critical to immediately call an ambulance and be transported to a specialized stroke center. The quicker a patient can get to a stroke team, the quicker an intervention can be ...

In a randomized clinical trial, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms first appeared ... improved stroke patients' recovery by more than 50% when ...

Herman Stack, a stroke survivor, is making big strides in recovery thanks to Vivistim therapy, a first-of-its-kind treatment in North Dakota.